Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 220

Total Visits per Month

March 2016 April 2016 May 2016 June 2016 July 2016 August 2016 September 2016
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 1 4 3 7 4 16 5

File Downloads

Views
dce-mri abstract.pdf 30

Top Country Views

Views
United States 62
Canada 28
France 14
China 9
Russia 9
United Kingdom 8
Germany 6
Sweden 5
Netherlands 4
Italy 3

Top City Views

Views
Miami Beach 23
Toronto 12
Ottawa 9
Santa Clara 6
Zhengzhou 6
Kansas City 5
Nynäs 5
Dundas 3
Munich 3
Beijing 2